Aadi Bioscience is a Biotech company based in Pacific Palisades, CA. It has raised $265M in total funding. Latest round: IPO.
Aadi Bioscience funding overview
Aadi Bioscience is a Biotech company based in Pacific Palisades, CA. Aadi Bioscience has raised $265M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in August 2021. The round record for Aadi Bioscience runs through 2021; nothing later has been disclosed. Investors on record include Hermed Capital, Celgene Corporation, Vivo Capital, Decheng Capital, Helsinn Investment Fund, Star Summit Ventures. 6 distinct backers are named across the disclosed rounds.
Aadi Bioscience at a glance
Total raised
$265M
Latest round
IPO
Latest round date
August 2021
Industry
Biotech
Headquarters
Pacific Palisades, CA
Notable investors
Hermed Capital, Celgene Corporation, Vivo Capital, Decheng Capital, Helsinn Investment Fund, Star Summit Ventures
Frequently asked about Aadi Bioscience funding
How much has Aadi Bioscience raised?
Aadi Bioscience has raised $265M in total disclosed funding across the rounds on record.
Who has invested in Aadi Bioscience?
Hermed Capital, Celgene Corporation, Vivo Capital, Decheng Capital, Helsinn Investment Fund, Star Summit Ventures are named among the investors backing Aadi Bioscience.
What was the latest Aadi Bioscience funding round?
The most recent disclosed round is an IPO, announced in August 2021.
Where is Aadi Bioscience based?
Aadi Bioscience is based in Pacific Palisades, CA.
What sector does Aadi Bioscience operate in?
Aadi Bioscience is tracked under Biotech from Pacific Palisades, CA, with $265M in disclosed funding.
When did Aadi Bioscience last raise?
The last disclosed Aadi Bioscience round closed in August 2021 at IPO.
We update the Aadi Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Pacific Palisades and their backers are listed below.
